BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 31176762)

  • 1. PDT with PPIX absorption peaks adjusted wavelengths: Safety and efficacy of a new irradiation procedure for actinic keratoses on the head.
    von Dobbeler C; Schmitz L; Dicke K; Szeimies RM; Dirschka T
    Photodiagnosis Photodyn Ther; 2019 Sep; 27():198-202. PubMed ID: 31176762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pretreatment with ablative fractional carbon dioxide laser improves treatment efficacy in a synergistic PDT protocol for actinic keratoses on the head.
    Falkenberg C; Schmitz L; Dicke K; Dervenis V; Szeimies RM; Dirschka T
    Photodiagnosis Photodyn Ther; 2021 Jun; 34():102249. PubMed ID: 33711530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Daylight photodynamic therapy for severe facial and scalp actinic keratosis: a prospective non-sponsored single-centre study employing the actinic keratosis area and severity index (AKASI).
    Jordan M; Ghoreschi K; Eberle FC
    Eur J Dermatol; 2019 Feb; 29(1):67-74. PubMed ID: 30827943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Photodynamic therapy leads to significant improvement of actinic keratosis area and severity index (AKASI).
    Schmitz L; von Dobbeler C; Gupta G; Gambichler T; Szeimies RM; Morton CA; Dirschka T
    Photodiagnosis Photodyn Ther; 2018 Mar; 21():66-70. PubMed ID: 29051122
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Daylight photodynamic therapy with methyl aminolevulinate cream is effective and nearly painless in treating actinic keratoses: a randomised, investigator-blinded, controlled, phase III study throughout Europe.
    Lacour JP; Ulrich C; Gilaberte Y; Von Felbert V; Basset-Seguin N; Dreno B; Girard C; Redondo P; Serra-Guillen C; Synnerstad I; Tarstedt M; Tsianakas A; Venema AW; Kelleners-Smeets N; Adamski H; Perez-Garcia B; Gerritsen MJ; Leclerc S; Kerrouche N; Szeimies RM
    J Eur Acad Dermatol Venereol; 2015 Dec; 29(12):2342-8. PubMed ID: 26435363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Actinic keratosis area and severity index is not correlated with photodynamic therapy procedural pain.
    Sharma A; Vincent L
    Photodiagnosis Photodyn Ther; 2020 Sep; 31():101946. PubMed ID: 32795507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single versus two-treatment schedule of methyl aminolevulinate daylight photodynamic therapy for actinic keratosis of the face and scalp: An intra-patient randomized trial.
    Gutiérrez García-Rodrigo C; Pellegrini C; Piccioni A; Tambone S; Fargnoli MC
    Photodiagnosis Photodyn Ther; 2019 Sep; 27():100-104. PubMed ID: 31141730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Daylight photodynamic therapy: the Southern California experience.
    Lane KL; Hovenic W; Ball K; Zachary CB
    Lasers Surg Med; 2015 Feb; 47(2):168-72. PubMed ID: 25663047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conventional versus daylight photodynamic therapy for actinic keratosis: A randomized and prospective study in China.
    Zhu L; Wang P; Zhang G; Zhang L; Liu X; Hu C; Yang X; Sroka R; Zhou Z; Wang X
    Photodiagnosis Photodyn Ther; 2018 Dec; 24():366-371. PubMed ID: 30336290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A multicenter, randomized, vehicle-controlled phase 2 study of blue light photodynamic therapy with aminolevulinic acid HCl 20% topical solution for the treatment of actinic keratoses on the upper extremities: the effect of occlusion during the drug incubation period.
    Schmieder GJ; Huang EY; Jarratt M
    J Drugs Dermatol; 2012 Dec; 11(12):1483-9. PubMed ID: 23377520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conventional vs. daylight methyl aminolevulinate photodynamic therapy for actinic keratosis of the face and scalp: an intra-patient, prospective, comparison study in Italy.
    Fargnoli MC; Piccioni A; Neri L; Tambone S; Pellegrini C; Peris K
    J Eur Acad Dermatol Venereol; 2015 Oct; 29(10):1926-32. PubMed ID: 25809617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Weather conditions and daylight-mediated photodynamic therapy: protoporphyrin IX-weighted daylight doses measured in six geographical locations.
    Wiegell SR; Fabricius S; Heydenreich J; Enk CD; Rosso S; Bäumler W; Baldursson BT; Wulf HC
    Br J Dermatol; 2013 Jan; 168(1):186-91. PubMed ID: 22860885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Daylight-mediated photodynamic therapy of moderate to thick actinic keratoses of the face and scalp: a randomized multicentre study.
    Wiegell SR; Fabricius S; Gniadecka M; Stender IM; Berne B; Kroon S; Andersen BL; Mørk C; Sandberg C; Ibler KS; Jemec GB; Brocks KM; Philipsen PA; Heydenreich J; Hædersdal M; Wulf HC
    Br J Dermatol; 2012 Jun; 166(6):1327-32. PubMed ID: 22250644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of 5-Aminolevulinic Acid and Daylight Photodynamic Therapy for the Treatment of Actinic Keratoses.
    Shive ML; Coakley BJ; Bierman DF; Serowka Lane KL; Wiegell SR; Haedersdal M; Zachary CB
    Dermatol Surg; 2019 Apr; 45(4):529-535. PubMed ID: 30807390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pre-treatment protoporphyrin IX concentration in actinic keratosis lesions may be a predictive biomarker of response to aminolevulinic-acid based photodynamic therapy.
    Kanick SC; Davis SC; Zhao Y; Sheehan KL; Hasan T; Maytin EV; Pogue BW; Chapman MS
    Photodiagnosis Photodyn Ther; 2015 Dec; 12(4):561-6. PubMed ID: 26480810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized split-scalp study comparing calcipotriol-assisted methyl aminolaevulinate photodynamic therapy (MAL-PDT) with conventional MAL-PDT for the treatment of actinic keratosis.
    Torezan L; Grinblat B; Haedersdal M; Valente N; Festa-Neto C; Szeimies RM
    Br J Dermatol; 2018 Oct; 179(4):829-835. PubMed ID: 29476546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Daylight photodynamic therapy with methyl aminolevulinate cream as a convenient, similarly effective, nearly painless alternative to conventional photodynamic therapy in actinic keratosis treatment: a randomized controlled trial.
    Rubel DM; Spelman L; Murrell DF; See JA; Hewitt D; Foley P; Bosc C; Kerob D; Kerrouche N; Wulf HC; Shumack S
    Br J Dermatol; 2014 Nov; 171(5):1164-71. PubMed ID: 24861492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of retinoid pretreatment on outcomes of patients treated by photodynamic therapy for actinic keratosis of the hand and forearm.
    Galitzer BI
    J Drugs Dermatol; 2011 Oct; 10(10):1124-32. PubMed ID: 21968662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Daylight photodynamic therapy for actinic keratoses: a randomized double-blinded nonsponsored prospective study comparing 5-aminolaevulinic acid nanoemulsion (BF-200) with methyl-5-aminolaevulinate.
    Neittaanmäki-Perttu N; Karppinen TT; Grönroos M; Tani TT; Snellman E
    Br J Dermatol; 2014 Nov; 171(5):1172-80. PubMed ID: 25109244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intraindividual, right-left comparison of topical 5-aminolevulinic acid photodynamic therapy vs. 5% imiquimod cream for actinic keratoses on the upper extremities.
    Sotiriou E; Apalla Z; Maliamani F; Zaparas N; Panagiotidou D; Ioannides D
    J Eur Acad Dermatol Venereol; 2009 Sep; 23(9):1061-5. PubMed ID: 19470041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.